Dysautonomia due to reduced cholinergic neurotransmission causes cardiac remodeling and heart failure.
about
Cholinergic activity as a new target in diseases of the heartElimination of the vesicular acetylcholine transporter in the striatum reveals regulation of behaviour by cholinergic-glutamatergic co-transmission.Quantal release of acetylcholine in mice with reduced levels of the vesicular acetylcholine transporterNovel strains of mice deficient for the vesicular acetylcholine transporter: insights on transcriptional regulation and control of locomotor behavior.Transgenic overexpression of the presynaptic choline transporter elevates acetylcholine levels and augments motor endurance.Pyridostigmine restores cardiac autonomic balance after small myocardial infarction in miceAn analysis of the myocardial transcriptome in a mouse model of cardiac dysfunction with decreased cholinergic neurotransmission.Reduced expression of the vesicular acetylcholine transporter and neurotransmitter content affects synaptic vesicle distribution and shape in mouse neuromuscular junction.Cholinergic signaling exerts protective effects in models of sympathetic hyperactivity-induced cardiac dysfunction.Pulmonary inflammation is regulated by the levels of the vesicular acetylcholine transporter.Whole-Retina Reduced Electrophysiological Activity in Mice Bearing Retina-Specific Deletion of Vesicular Acetylcholine TransporterCardiomyocyte-secreted acetylcholine is required for maintenance of homeostasis in the heartAutonomic cardiac innervation: development and adult plasticity.Aerobic exercise training in heart failure: impact on sympathetic hyperactivity and cardiac and skeletal muscle function.Cardiomyocyte dysfunction during the chronic phase of Chagas disease.Cardioprotective Action of Ginkgo biloba Extract against Sustained β-Adrenergic Stimulation Occurs via Activation of M2/NO Pathway.Vesicular acetylcholine transporter defect underlies devastating congenital myasthenia syndrome.VAChT knock-down mice show normal prepulse inhibition but disrupted long-term habituation.Cardiac autonomic modulation induced by doxorubicin in a rodent model of colorectal cancer and the influence of fullerenol pretreatment.Nicotinic acetylcholine receptor-mediated protection of the rat heart exposed to ischemia reperfusion.Long-term administration of pyridostigmine attenuates pressure overload-induced cardiac hypertrophy by inhibiting calcineurin signalling.Electrophysiological and pharmacological evaluation of the nicotinic cholinergic system in chagasic rats.Variants in SLC18A3, vesicular acetylcholine transporter, cause congenital myasthenic syndrome.Non-neuronal cholinergic machinery present in cardiomyocytes offsets hypertrophic signalsAutonomic cardiocirculatory control in mice with reduced expression of the vesicular acetylcholine transporter.The influence of two functional genetic variants of GRK5 on tau phosphorylation and their association with Alzheimer's disease risk.The autonomic nervous system as a therapeutic target in heart failure: a scientific position statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.Pyridostigmine Improves the Effects of Resistance Exercise Training after Myocardial Infarction in Rats.
P2860
Q27004543-E021B495-295B-478F-8B84-C2C818459805Q30472919-71A1D42E-A74E-4B96-B81E-705D92578ED1Q33836058-FCBE3D1A-85E3-4F82-9A26-41D6EE48DAC3Q33851514-C29E239D-A639-41A3-8458-9EC09D7BE6AAQ33924266-ABFDF360-7063-48AE-8AA7-C0CCD39FA6C6Q34061367-6DA433B7-6216-4105-83C5-B18B7BE87E20Q34328505-F6C2AB67-7EF9-4427-BF72-D0164E7EBC19Q35048052-5BEA062D-A2F8-42C5-9716-E252B1D6EA0AQ35200653-B01F2EDD-20DB-4606-80A7-AA4FA5AF957DQ35225202-549634D2-2DD0-4ED1-BFB8-8313EAC1733CQ35727248-E5E7E6C0-F2B4-4340-AD00-C009EE363E19Q37327512-871CACF4-7632-43AF-A1A1-1BE7C70DE4FCQ37496525-0CB0E64E-6EF5-4724-A426-43545AA032EAQ37940294-E894DE36-A12E-47D3-8E15-443C4CB6DEFAQ38567925-0A8C2F48-FC71-4AA5-A587-99D0A2F0C9CCQ38759008-CA27E114-6548-4331-839F-3B1AD1F1F50BQ39201011-A0A1393C-AC74-4290-BD24-18ED7097F531Q39772130-8A33EC3F-56D7-4B7C-9BE7-B2162256ECADQ41072198-039A3B99-98B4-4F10-8778-26D002357CD4Q41097787-C9219258-E92D-4993-9A42-C7D8B90C03EAQ41520454-17BBEC61-C8B9-4A53-B70F-ECFF41FBF3F9Q41857083-7EEB633A-2C01-48C7-84DF-E3C2DAA688A1Q42113919-D3E69514-0BD1-4A6D-98F4-29B94F929B1EQ42248727-0128252A-F3A8-474D-B678-341A86A7ED09Q42478597-E38F10EC-72B3-4182-84D3-F3A7CA5649ECQ42654068-2B0EB9CD-EC1A-492C-BC33-428950159D4BQ47631903-6ECB0232-6CB0-4DCA-B213-D105B1A1A383Q50329856-DC71E4A5-4178-46D2-A1BD-DACF598F827B
P2860
Dysautonomia due to reduced cholinergic neurotransmission causes cardiac remodeling and heart failure.
description
2010 nî lūn-bûn
@nan
2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Dysautonomia due to reduced ch ...... remodeling and heart failure.
@ast
Dysautonomia due to reduced ch ...... remodeling and heart failure.
@en
type
label
Dysautonomia due to reduced ch ...... remodeling and heart failure.
@ast
Dysautonomia due to reduced ch ...... remodeling and heart failure.
@en
prefLabel
Dysautonomia due to reduced ch ...... remodeling and heart failure.
@ast
Dysautonomia due to reduced ch ...... remodeling and heart failure.
@en
P2093
P2860
P50
P356
P1476
Dysautonomia due to reduced ch ...... remodeling and heart failure.
@en
P2093
Aline Lara
Alvair P de Almeida
Anderson J Ferreira
Anilton Vasconcelos
Carlos Roberto Bueno
Charles Mady
Cristiane A S Menezes
Danilo Roman-Campos
Denis D Damasceno
Diogo Guimarães
P2860
P304
P356
10.1128/MCB.00996-09
P407
P50
P577
2010-02-01T00:00:00Z